LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 73 filers reported holding LEGEND BIOTECH CORP in Q1 2021. The put-call ratio across all filers is 3.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,827,267 | -31.0% | 310,068 | -29.1% | 0.01% | -16.7% |
| Q2 2023 | $30,200,694 | +135.5% | 437,501 | +64.5% | 0.01% | +100.0% |
| Q1 2023 | $12,825,845 | +24.5% | 265,986 | +28.9% | 0.00% | +50.0% |
| Q4 2022 | $10,303,638 | -54.6% | 206,403 | -62.9% | 0.00% | -60.0% |
| Q3 2022 | $22,712,000 | -1.3% | 556,658 | +33.1% | 0.01% | 0.0% |
| Q2 2022 | $23,008,000 | +72.6% | 418,328 | +14.0% | 0.01% | +66.7% |
| Q1 2022 | $13,332,000 | +30.6% | 366,864 | +67.5% | 0.00% | +50.0% |
| Q4 2021 | $10,209,000 | +169.8% | 219,034 | +192.7% | 0.00% | +100.0% |
| Q3 2021 | $3,784,000 | +71.5% | 74,844 | +39.2% | 0.00% | – |
| Q2 2021 | $2,207,000 | +808.2% | 53,757 | +542.9% | 0.00% | – |
| Q1 2021 | $243,000 | -40.4% | 8,362 | -42.3% | 0.00% | – |
| Q4 2020 | $408,000 | – | 14,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |